Tag: Drugs

Bartell Drugs, a local, family-owned business for 130 years, to be sold to Rite Aid for $95 million

After months of pandemic-related financial strain and years of uncertainty over its future, Bartell Drugs, one of the oldest companies in Washington state and one of the most familiar names in the Seattle business community, is being sold.

The 67-store regional drugstore chain, which has been owned by the same family since its founding in Seattle’s Central District in 1890, will be acquired by Rite Aid for $95 million, the companies announced Wednesday. 

“We felt that this was the only answer,” said George D. Bartell, co-owner and chairman of the company his grandfather, George H. Bartell Sr., founded 130 years ago. “It was getting more difficult for regional operators to compete in the market.”

Pennsylvania-based Rite Aid, which has about 2,500 stores in 19 states, including 69 in and around Seattle, will keep the Bartell name on the stores. It disclosed no plans to close stores or cut any of

Read More

Global Biological Drugs Market 2020 to 2025 – Top Manufacturers, Business Strategy and Forecast Report

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (CDN Newswire via Comtex) —
The recently introduced report titled Global Biological Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 provides an in-depth evaluation of historic facts (2015-2019) and forecasted data (2020-2025). The report gives market analysis on a worldwide scale, for instance, present and traditional growth analysis, competitive analysis, as well as the growth prospects of the central regions. The report consists of a thorough evaluation of the driving forces of the global Biological Drugs market. The market is monitored based on segments along with type, application, and end-user. The report analyzes the industry trends in each of the sub-segments, from sales, revenue, and consumption.

The report highlights core business values, market trends, revenue growth patterns market shares, and demand and supply, production, key regions, revenue rate, and key

Read More

Gruthan Bioscience to develop new class of cholesterol-lowering drugs

Gruthan Bioscience, LLC, a Medical University of South Carolina startup based in Charleston, South Carolina, received a Small Business technology Transfer (STTR) award from the National Heart, Blood and Lung Institute in August to take the next step in developing a novel class of cholesterol-lowering drugs to treat familial hypercholesterolemia.

The startup was founded by liver researcher Stephen Duncan, Ph.D., SmartState Chair in Regenerative Medicine and chairman of the Department of Regenerative Medicine and Cell Biology at MUSC.

Patients with familial hypercholesterolemia have very high levels of low-density lipoprotein cholesterol (LDL-C), colloquially known as “bad cholesterol.” The receptor that should bind to the cholesterol and remove it from the blood is mutated and no longer functions.

A subset of these patients inherit mutations in the LDL receptor from both parents and are at high risk of developing severe and deadly cardiovascular disease

Read More

Chronic Obstructive Pulmonary Disease Drugs Market | Industry Analysis By Global COVID-19 Impact On Healthcare Sector And Business

The MarketWatch News Department was not involved in the creation of this content.

Sep 23, 2020 (The Expresswire) —
Fortune Business Insights Published “Chronic Obstructive Pulmonary Disease Drugs Market” 2020 Size, Share Estimation, Growth Projection, Emerging Trends And Global Industry Analysis 2026 latest depth analysis market research report. Global Chronic Obstructive Pulmonary Disease Drugs Market Report contains comprehensive information about current market situation impacted by COVID-19, forecast growth, segments that have most impacted by COVID-19, and Emerging Trends in 2020. Report also discusses Chronic Obstructive Pulmonary Disease Drugs business growth strategies, competitive analysis, regional market insights, emerging key companies in market.

Report segments information on Global Chronic Obstructive Pulmonary Disease Drugs By Drug Class (Bronchodilators, Steroids, Combination drugs), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), and Geography Forecast till 2026.

Get Sample Report Copy On COVID-19 Impact On Global Chronic Obstructive Pulmonary Disease Drugs Market

Global Chronic Obstructive

Read More

Global Poultry Drugs Market 2020 Top Manufacturers, Industry Challenges, Business Strategies, Revenue Value and Competitive Landscape to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (CDN Newswire via Comtex) —
MarketandResearch.biz has provided qualitative and informative knowledge by adding titled Global Poultry Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 that recognizes, explains, and forecasts that the global market. The report provides an organized consideration analysis with projections for the market players. The report aims to ease the understanding of global Poultry Drugs market estimates through statistical and numerical data in the form of tables, graphs, and charts. The research offers a calculated assessment of the new recent developments, import-export analysis, production analysis, market share, market players, opportunities, strategic market growth, and market size. The report provides detailed information on major market competitors and emerging companies with significant market share based on high-quality demand, revenue, sales, and product manufacturers.

Market Dynamics:

Different parameters are used

Read More

Urinary Drugs Market Industry Growth and Demand, Product Overview, Company Profiles and Recent Business Development, Forecast to 2020-2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 10, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry”.

Global “Urinary Drugs Market” report business can effectively gain a holistic view of the market and then also benchmark all the companies in the industry. Analysts have studied the data of revenue, production, and manufacturers of each region. Understanding the segments helps in identifying the importance of different factors that aid the market growth. This report represents overall Urinary Drugs market size by analyzing historical data and future prospect. It also provides useful recommendations for new as well as established players of the Urinary Drugs market.

Segments of the Urinary Drugs market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. Market participants can use the analysis on market

Read More

2024 Germany Drugs of Abuse Testing Market: Supplier Shares and Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2024 Germany Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering.

This report provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per

Read More